Sira 10
Alternative Names: Sira-10Latest Information Update: 06 Sep 2023
At a glance
- Originator Siragen Pharmaceuticals
- Class Small molecules
- Mechanism of Action Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Alzheimer's disease; Psychiatric disorders
Highest Development Phases
- Discontinued Alzheimer's disease; Psychiatric disorders
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)
- 06 Sep 2023 Discontinued - Preclinical for Psychiatric disorders in USA (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Alzheimer's-disease in USA